| 摘要 |
The invention is directed to the use of an ester derivatives of triptolide, tripdiolide, 16-hydroxytriptolide, a pharmaceutically acceptable salt thereof, or a combination thereof, for the manufacture of a medicament comprising the triptolide prodrug for the treatment of acute myeloid leukemia.
|
